Warning message

  • Selective filter "Institution (selective)" has limited the amount of total results. Please, review you query configuration.
  • Selective filter "Project (selective)" has limited the amount of total results. Please, review you query configuration.

NTD ConnectOR ~ Advanced search

Displaying 271 - 296 of 296

Side-by-side comparison of village-based sampling for Skin snip MF vs. Ov16 ELISA

To compare skin snip microfiladermia with antibody responses against Ov16 antigen in general population in epidemiological assessments post CDTi.

Countries: Senegal

Field evaluation of two schistosome antibody-based rapid tests at point-of-care for prevalence mapping of urinary schistosomiasis in The Gambia

CCA Protocol: To know the sensitivity and specificity of POC CCA in the detection of urinary schistosomiasis, as compared to traditional diagnostic tools.

Countries: Gambia
Diseases: Schistosomiasis

Multi-country perspective on mobile data collection

SCORE Data Collection on Mobile Devises

Diseases: Schistosomiasis

Snail control in Kenya with 20 year follow-up

Snail Control follow-up study of P. clarkii 20 years later

Countries: Kenya
Diseases: Schistosomiasis

Analysis of schistosomiasis diagnostics

Human Diagnostics Tool Development (CAA diagnostic tool)

Countries: Tanzania
Diseases: Schistosomiasis

Cross-country analysis of CCA test for screening/mapping

POC/CCA screening/mapping tool initial Studies

Diseases: Schistosomiasis

Comparison of CCA and PCR

Screening Tool POC/CCA: PCR comparative studies

Countries: Kenya
Diseases: Schistosomiasis

Identifying CCA testing standards in Kenya

POC/CCA tool ongoing studies: Use of testing standards; reader differences; ‘Trace’ result analyses

Countries: Kenya
Diseases: Schistosomiasis

Cost-effectiveness analysis of schistosomiasis control

Cost Studies in SCORE Gaining and Sustaining

Diseases: Schistosomiasis

Mapping of Schistosomiasis in Rwanda and Burundi

Mapping of schistosomiasis (Sm)

Countries: Burundi | Rwanda
Diseases: Schistosomiasis

Identifying schistosomiasis genetic markers in Brazil

Develop genetic markers for S. haematobium

Diseases: Schistosomiasis

Schistosomiasis population genetics in Niger and Tanzania

Schistosome Population Genetics in Gaining Control Studies in Niger (Sh) and Tanzania (Sm)

Countries: Niger | Tanzania
Diseases: Schistosomiasis

Snail control in Niger and Tanzania

Part of gaining control studies

Countries: Niger | Tanzania
Diseases: Schistosomiasis

Gaining schistosomiasis control in Kenya, Mozambique, and Tanzania

Gaining Control: >25% Prevalence MDA strategies; and subtle morbidity of Cohort; Population genetics, and snail monitoring

Countries: Kenya | Mozambique | Tanzania

Sustaining and gaining schistosomiasis control in Niger

Sustaining / Gaining Control with Single versus Double Treatment; and Population genetics, snail monitoring

Countries: Niger

Sustaining schistosomiasis control in Cote D'Ivoire and Kenya

MDA strategies: Sustaining control at 10 – 24% prevalence

Countries: Cote d'Ivoire | Kenya

Schistosomiasis elimination in Zanzibar

(1) Is it possible to eliminate schistosomiasis as a public health problem on Unguja in three years and to interrupt transmission in five years? (2) Is it possible to control schistosomiasis throughout Pemba (prevalence <10%) in three years and to eliminate it as a public health problem in five years? (3) What are the costs, successful strategies, barriers, etc. associated with three different interventions (MDA, vector control, and behavior change)?

Countries: Tanzania
Diseases: Schistosomiasis

Randomized trial of Ivermectin/Albendazole vs. Ivermectin alone

Randomized clinical trail comparing treatment with Albendazole and Ivermectin to Ivermectin alone for Onchocerciasis.

Countries: Ghana | Ghana
Diseases: Onchocerciasis

Randomized trial of albendazole alone for LF in Cote d'Ivoire

Randomized Clinical Trial of Albendazole vs Ivermectin+Albendazole for lymphatic filariasis treatment and elimination.

Countries: Cote d'Ivoire

Randomized trial of triple therapy (DEC/Alb/Iver) in Papua New Guinea

Randomized Clinical Trial comparing triple triple therapy of DEC/Alb/Iver vs. DEC/Alb alone

Countries: Papua New Guinea

Analysis of MDA frequency and Brugia in Indonesia

Comparison of 2X vs. 1X per year MDA on Brugia with MDA of DEC/Alb , plus STH evaluation

Countries: Indonesia

Analysis of MDA for LF in loa endemic countries

Community MDA with 2X Alb alone for W. bancrofti in areas co-endemic for L. loa, plus STH evaluation

Countries: Congo | Dem. Rep. of Congo

Comparison of Filariasis Binax Test and Alere Test Strip

Binax Now Filariasis Test vs. Alere Filariasis Test Strip Comparison

Countries: Liberia | Indonesia | Sri Lanka

Analysis of MDA frequency in Liberia and Cote D'Ivoire

Comparison of 2X vs. 1X per year MDA on W. bancrofti with MDA of IVM/Alb, plus STH evaluation (and Schistosoma in Foya only)

Countries: Liberia | Cote d'Ivoire | Liberia

Analysis of MDA frequency in Indonesia and Papua New Guinea

Comparison of 2X vs. 1X per year MDA, W. bancrofti with MDA of DEC/Alb, plus STH evaluation